Schedule 13D ownership disclosure

Arcturus Therapeutics Holdings Inc

Security class unavailable · CUSIP: 03969T109

Event date: 2019-06-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,678,036
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-19-023496
Form type
SC 13D
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Jun 26, 2019
Reporting period
Jun 19, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub